New hope for Hard-to-Treat lymphoma? drug targets cancer even when marker is low
Disease control
Completed
This study tested a drug called brentuximab vedotin in 23 people with a rare type of T-cell lymphoma that had stopped responding to or returned after prior chemotherapy. The drug is designed to seek out and kill cancer cells that have a specific marker called CD30, even when leve…
Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control
Last updated Apr 29, 2026 09:48 UTC